Global Oxaliplatin Market and Forecast 2020-2026

  • TBI408864
  • October 07, 2020
  • Global
  • 132 pages
  • IFF Market Research
                                              Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddys laboratories, Teva and Jiangsu Hengrui Medicine.

Market Analysis and Insights: Global Oxaliplatin Market

The research report studies the Oxaliplatin market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market. The global Oxaliplatin market size is projected to reach US$ 976.5 million by 2026, from US$ 867.1 million in 2020, at a CAGR of 2.0% during 2021-2026.

Global Oxaliplatin Scope and Segment

The global Oxaliplatin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oxaliplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

by Type, the market is primarily split into

  • Mannitol
  • Glucose Solution
  • Lactose Solution
  • Other

by Application, this report covers the following segments

  • Colorectal Cancer
  • Stomach Cancer
  • Ovarian Cancer
  • Other
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

The Oxaliplatin key players in this market include:

  • Sanofi-Aventis
  • Yakult honsha
  • Dr Reddys laboratories
  • Sun Pharmaceutical
  • Teva
  • Fresenius Kabi
  • Hospira
  • Mylan
  • Jiangsu Hengrui Medicine
  • Nanjing Pharmaceutical Factory
  • Jiangsu Aosaikang Pharmaceutical
  • Qilu Pharmaceutical
  • Hisun Pharmaceutical
  • Lunan Pharmaceutical
  • Luoxin
  • Halfsky Pharmacy
  • YRPG
  • Hainan Jinrui Pharmaceutical
  • Jari Pharmaceutical
  • Chiatai Tianqing

Table of Contents

Chapter 1. Preface
	
		1.1. Report Description
		
			1.1.1. Objective
			1.1.2. Target Audience
			1.1.3. Unique Selling Proposition (USP) & Offerings
		
		
		1.2. Research Scope
		1.3. Research Methodology
		
			1.3.1. Market Research Process
			1.3.2. Market Research Methodology
			1.3.3. Level 1: Primary Research
			1.3.4. Level 2: Secondary Research
			1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
			
Chapter 2. Executive Summary
	
		2.1. Global Oxaliplatin 2019-2029 (USD Billion)
		2.2. Global Oxaliplatin: Market Snapshot
	 
Chapter 3. Global Oxaliplatin - Industry Analysis
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form